With reference to its letter dated June 29, 2022 informing about the 63rd Annual General Meeting (AGM) of the company which is scheduled to be held on Monday, August 29, 2022 at 11.30 am (IST) through Video Conferencing (VC)/ Other Audio-Visual Means (‘OAVM’) and pursuant to Regulation 34(1) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Kopran has informed that the copy of the Annual Report for the FY2021-22, along with the Notice of 63rd Annual General Meeting (AGM) for the records. The said Annual Report shall be sent to the Members through electronic mode, whose email ids are registered with the Company/ Depositories. The Annual Report is also available on the company’s website given below: https://www.kopran.com/investors/financials/pdf/Annual%20Report%202021-22.pdf.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: